Posts in Pharmaceutical & Life Sciences

Thermal Protection Buyer’s Guide Pt. 1

April 28th, 2022 Posted by Manufacturing, Pharmaceutical & Life Sciences, Transportation 0 thoughts on “Thermal Protection Buyer’s Guide Pt. 1”

Thermal Protection Buyer’s Guide Pt. 1

A definitive resource for shipping pharma, life sciences and healthcare products

Buying thermal protection shouldn’t be a gamble. If you’re a shipper of pharmaceutical, healthcare, or life sciences products, you understand that payload integrity is of the utmost importance. But there is a myriad of thermal protection suppliers in the industry, all promising to solve your thermal shipping challenges.


So, how do you choose the right thermal protection supplier for you? Unfortunately, many buyers don’t know what to look for, or worse — may shop on price alone. In this guide, we’ll look at what the right thermal protection supplier should be doing, and questions to ask a supplier before making a buying decision.


Let’s look at 6 Considerations you should discuss with every potential supplier.


  1. Performance

The real world doesn’t operate by test chamber, and you shouldn’t either. Any supplier can show you pre-planned graphs of well-controlled test scenarios. Ask for more. Ask for real world results on actual shipping lanes and ask if they have any third-party independent tests.


  1. Thermal Options

No two shipping lanes are the same. Let’s face it, meeting pharmaceutical product requirements are difficult. No two payloads, or shipping lanes are the same and for every instance, the onus rests on the shipper to ensure the product’s integrity remains intact through to its final destination. Therefore, it is important to find a supplier with a robust offering of thermal options.


  1. Application Versatility

Do you want to manage one supplier, or many? It would certainly be easier if pharmaceutical shippers faced the same payloads and same applications every day. But we know that’s not the case. Stringent product requirements, applications, regions, transit times and more, vary greatly. Check if your thermal protection supplier has you covered over land, air, and sea.


  1. Availability

Healthcare is always time sensitive. Availability should be a key consideration before deciding on a thermal shipping supplier. Many times, a supplier will prioritize a prospect with quick replies, and fast turnarounds for samples and quotes. But once you enter a long-term contract, ask how your supplier will continue to be timely, responsive, and reliable in the future.


  1. Sustainability

It’s all in the details. Sustainability is more than just eco-friendly materials. It is the whole process of how the product is imagined, from raw material sourcing through the production process, transport, and wastage. “Green” is not black and white. Too many suppliers claim to be sustainable without detailing exactly how their overall process creates value for you or your customer.


  1. Asset Tracking

Thermal protection suppliers should be more than thermal protection. Anyone can sell you a thermal cover. But what happens after that? The difference between an insulation seller and a true cold chain partner is what they can offer you beyond the product itself. Consider a supplier that can help you manage your inventory of thermal covers.



The right supplier can make or break your business. If your supplier isn’t reliable or if the quality starts to slip, then your business will also struggle to provide reliable service. Or perhaps worse, will leave you scrambling and wasting unnecessary dollars trying to remedy their shortfalls.


Ready to get started?


A call or email to QProducts & Services is a great way to start the search. Even if we’re not the right supplier for you, we’d love to get you set on the right path.


Written by Tony Dellumo, Marketing Manager at QProducts & Services

Supply Chain Risk: COVID-19’s Continued Impact on Airfreight and Cold Chain Logistics

August 10th, 2021 Posted by Air, Food & Beverage, Pharmaceutical & Life Sciences, Temperature Protection 0 thoughts on “Supply Chain Risk: COVID-19’s Continued Impact on Airfreight and Cold Chain Logistics”

Author: Tony Dellumo, Marketing Manager at QProducts & Services


Supply Chain Risk: COVID-19’s Continued Impact on Airfreight and Cold Chain Logistics


By Tony Dellumo – Marketing Manager, QProducts & Services


Prior to COVID-19, 20K airplanes were in the air globally, on any given day. According to Time Magazine, when COVID-19 hit, 16K were grounded. In the U.S. alone, air travel dropped 95%. Globally it dropped 62%,  thus effectively stopping air cargo transportation as we know it.


In the meantime, the need for medication, medical devices, PPE, food, water, and other necessities remained. We started seeing passenger aircraft being repurposed into cargo aircraft along with other efforts to try and keep the supply chain moving. Eventually, capacity for the transportation of goods across all modes of transportation, was at an all-time low.


Shortage of equipment like temp-controlled containers, major delays, and high prices stacked up to create tough scenarios for companies trying to keep their products moving out the door while maintaining product integrity and delivering in a timely manner. Delays were persistent and were scattered throughout the shipping process. “You could still book airfreight, but the carrier wasn’t showing show up in one or two days anymore. It could be six to seven days later before your freight went out the door. Once arriving at the airport, what once was a one or two-hour holding time had turned into six or seven hours before your cargo made it into the airport,” says Jim O’Donnell, Director of Pharma and Chemical Logistics at QPS. “This due to lack of staff, increased security protocols, etc., according to truck drivers.” With the tarmac backed-up with many flights’ worth of airfreight, cargo was subjected to double, even triple the normal tarmac time, putting freight at risk to the elements such as sun, wind, and moisture.


Manufacturers shipping by air were forced to use more robust protection to maintain temps with longer tarmac times. With even an extra half or full hour of tarmac time, the impact of the sun can be extreme. It seemed that shippers were scrambling to figure out how to work around delays by even changing the mode of transportation. Switching to ocean freight was an option but weighing longer transit times with quality risk and the customer service impacts of both, was yet another factor shippers were taking into consideration. With capacity for temperature-controlled shipping at its lowest levels compounded by COVID-19 vaccine distribution, passive thermal protection, a long-proven but under-utilized temp-control solution, was quickly becoming the saving grace of the global cold chain not only on the tarmac but over land and sea as well.


Fast forward to summer 2021. The supply chain landscape has changed forever. While transportation networks have adapted, adjusted, and even evolved into better versions of themselves in many ways, these impacts are still being felt and navigated around in a major way. With the COVID-19 Delta Variant now sweeping the mostly un-vaccinated globe, new lockdowns and travel restriction threaten to tighten the noose around the global supply chain once again, and companies with agile, flexible, and smart transportation networks will have the upper hand.


To find out how QProduct & Services can help give your transportation network the elasticity it needs to navigate obstacles in your supply chain, click here and tell us about your unique shipping challenges.


Wonder how COVID-19 provided an opportunity for cargo thieves? Check out the infographic here.

covid19 vaccine

Cold Chain Capacity Crisis Looms Ahead of COVID-19. Are You Prepared?

November 20th, 2020 Posted by Manufacturing, Pharmaceutical & Life Sciences, Temperature Protection 0 thoughts on “Cold Chain Capacity Crisis Looms Ahead of COVID-19. Are You Prepared?”

Author: Tony Dellumo, Marketing Manager at QProducts & Services


Top players from cold chain logistics’ pharma, biologics, and the life sciences sector sound alarm on the upcoming burden on temperature-controlled shipping capacity as the global supply chain plans for the safe distribution of COVID-19 vaccines. These vaccines require strict temperature management, some as cold as -20 to -30° C.


As states begin to release their draft COVID-19 vaccine distribution plans, the vaccine cold chain requirements from manufacturer to patient present the biggest challenge these supply chains have seen throughout the course of this pandemic.


Compounded by the estimated 6.4 billion flu vaccines manufactured and distributed globally every year, the hundreds of millions of COVID-19 vaccine doses needed in the U.S. and tens of billions worldwide threaten to stretch temp-controlled resources thin due to the variety of stringent temperature guidelines attached to different types of COVID-19 vaccines in development. The leading candidates belong to the mRNA category of shots, touting an impressive storage/distribution requirement of -94⁰F, with only a 24-hour allowable excursion for refrigerated temperature exposure. Other protein sub-unit vaccines are capable of refrigerated storage for months, yet others garner temperature requirements of -4⁰F.


For those familiar with the escalating prices of temperature controlled air freight and ground transportation due to the normal increase in demand, service cost, and the additional stress of ongoing pandemic related issues, the need to scramble for alternatives under the pressure of vaccine distribution can be a stark reality. Inevitably, everyday temp-sensitive cargo will be squeezed out of their place in line for temp-controlled equipment, forcing shippers to become flexible in how they manage their logistics moving into 2021 and beyond.


How to Remain Flexible in a Capacity Crunch


Equipment Selection for the Right Products at the Right Time


  • Identify when you can ship safely without temperature-controlled equipment, utilizing passive thermal protection (i.e., pallet covers) to eliminate possible excursions, dry equipment during times when environmental risk is low enough, or a combination of both to avoid delays and service disruption.
  • Use what you know about your product specs, your shipping lanes, and your service providers.
  • Examine lane risk using weather data and product data of each shipment ahead of scheduling.


Protection on the Tarmac Without Paying for Active Containers


  • Reflective pallet covers with varying levels of insulation can maintain product temps for hours on the tarmac.
  • Add phase change materials like gels and pre-condition for pallet-shipper protection without the pallet shipper prices.


Transportation Mode Selection


  • Now is a good time to explore switching from air to ocean where applicable. It’s less expensive and more available with temp-controlled service.
  • Ocean freight excursions can be eliminated using breathable pallet covers that maintain pallet temps in refrigerated containers during off-shore and on-shore power outages.
  • Check out full container protection in the form of CargoQuilt®or Container Kit


QProducts & Services provides flexibility and alternatives to shipping temperature-sensitive freight by utilizing passive thermal protection and cargo security, including providing pallet protection for COVID-19 vaccine trials. For over 25 years, we have served the pharma, life sciences, and healthcare industries, helping in the safe distribution of CRT and 2-8⁰C products. With our ear to the ground throughout the COVID-19 pandemic, we have worked to continue manufacturing our American Made products full-time, in a commitment to keeping the supply chain and cold chains moving so people can get the healthcare products, medicine, and food they need every day despite COVID-19 disruptions. In hosting our Cold Chain Council webinars for our community of cold chain professionals from all industries, we invite you to join our Cold Chain Council LinkedIn group to share your insight on current challenges in your cold chain and add to the conversation!


Our most recent webinar featured Georgios Ampartzidis from the World Federation of Hemophilia and Ed De Reyes of Sabrewing Aircraft Company. They discussed ways to ship temp-sensitive and life-saving medications to remote and underdeveloped regions of the world. Interested in learning more? Listen to our webinar recording.


Still have questions? Feel free to contact us directly at

cold chain council

Cold Chain Council Introduces A New Webinar: How to Collaborate with CMOs to Boost Efficiency and Overcome Capacity Challenges in a Complex Supply Chain

September 3rd, 2020 Posted by Pharmaceutical & Life Sciences, Technology, Temperature Protection 0 thoughts on “Cold Chain Council Introduces A New Webinar: How to Collaborate with CMOs to Boost Efficiency and Overcome Capacity Challenges in a Complex Supply Chain”

Cold Chain Council Introduces A New Webinar: How to Collaborate with CMOs to Boost Efficiency and Overcome Capacity Challenges in a Complex Supply Chain

Published on: September 2020


Hazel Crest, IL

Release: May 2020

For immediate release.



The Cold Chain Council, hosted by QProducts & Services, is hosting their second webinar of 2020: How to Collaborate with CMOs to Boost Efficiency and Overcome Capacity Challenges in a Complex Supply Chain. Industry-leading speakers will provide insight and discussion about partnering with Contract Manufacturing Organizations (CMOs) to better manage capacity and risk, promote innovation, and improve efficiency when dealing with complex pandemic scenarios.


We invite you to join us on Tuesday, September 29th, at 11 AM CST as our speakers share examples and insight about partnering with Contract Manufacturing Organizations amid a new evolution of the supply chain. Register here for the upcoming webinar.


Industry-expert speakers will include:


  • Luiz Barberini, Operations Manager, External Manufacturing Latin America Head at Bayer. MBA, mechanical engineer, CQE, APICS CSCP and CPIM certified with three post-graduates in Marketing, Logistics, and Transports, Luiz has worked for more than 25 years in activities related to Supply Chain, Procurement, and Logistics. He also teaches Negotiation, Supply Chain, and Demand Management for some major post-graduation schools in São Paulo.


  • Jeff Tucker, CEO of Tucker Company Worldwide. Jeff Tucker is a third generation CEO of Tucker Company Worldwide, America’s oldest privately held freight brokerage specializing in complicated freight, like temperature-controlled, oversized, and high-value, high-security goods. Jeff is past chairman of the board for the Transportation Intermediaries Association (TIA). He also co-authors and chairs the committee for TIA’s Carrier Selection Framework.



Cold Chain Council began three years ago to gather top talent from all phases of the cold chain – including manufacturers, retail, distribution, and logistics partners – to share their perspectives on existing challenges and best practices. In 2020, we have taken our format from live, in-person events to live webinar events to safely continue and expand our ability to gather around industry experts to tackle the challenges and issues at hand. Visit and join the Cold Chain Council group on LinkedIn to engage and stay informed regarding industry topics and future Cold Chain Council events.



Contact Information:
Anthony Dellumo
Marketing Manager, QProducts & Services
Hazel Crest, IL

Sustainable Packaging in the Life Sciences and Healthcare Industry

July 7th, 2020 Posted by Manufacturing, Pharmaceutical & Life Sciences, Update 0 thoughts on “Sustainable Packaging in the Life Sciences and Healthcare Industry”

Sustainable Packaging in the Life Sciences and Healthcare Industry

Authors: QProducts & Services Digital Team, Under the Direction of Paul Yadron, Sr. VP of Sales




Sustainable packaging is and always has been a topic of discussion amongst vendors, suppliers, and customers in the life sciences and healthcare industries. The rate of acceptability is accelerating, and companies are adapting more than ever. In episode two of the Cold Chain Council Podcast, Peter Mirabella of QProducts and Services breaks down the factors that drive QProducts to implement sustainable packaging and practices into the products they build.

palletquilts in a box






















Q: How does QProducts and Services look at packaging sustainability and how is it different from years past?


A: We, as most of the world, want and need to improve the environment. From the air we breathe to minimizing the consumption of our natural resources, these are the basic driving factors. We would be foolish to think that cost is not part of this equation. As a manufacturer of packaging solutions, we are always balancing cost effectiveness with sustainable solutions. In the past, there was an “either/or” approach to packaging sustainability. For example, either developing an elaborate re-use program or the more challenging recyclable program. Now, it’s a matter of being good stewards of the world around us and making packaging sustainability a priority.



Q: Let’s talk about recycling and what that means with materials.


A: These are both challenging areas that require innovation by manufacturers such as QProducts and Services and those involved in Cold Chain Council. Of course, there is no one best answer but rather a multifaceted approach to attack sustainability. We incorporate technology, innovation in materials, collaboration with our customers, maximizing truckload capacities by packaging, and finally, looking at preferable recyclable materials.



Q: Why do we need to rethink packaging in life sciences and healthcare?


A: We need to rethink packaging in life sciences and healthcare because our customers drive us too. Although I say this, we know well that it is our customer’s customers and that being a society as a whole drive us to continue our innovation.



Q: Why aren’t there mature sustainable solutions today?


A: There has been and continues to be an evolution in both materials and manufacturing processes. As an engineer, we balance cost and material characteristics with what fits into reasonable assembly processes to fit the strict criteria to protect temperature-sensitive commodities. As engineers, we are limited with what and how these come together into a finished solution. As you may expect, these limitations result in less sustainable solutions. We continuously research materials we use in our solutions that are low cost and high performing and fit into our manufacturing process. There are always innovations going on from raw material properties to how they are converted into shapes we use to build solutions for our customers.


A perfect example I can share with you are materials used in the residential construction and home goods industries that transitioned into the packaging industry. Historically, the fabrics were either too narrow or too expensive. As technologies improved in how fabrics are manufactured and converted into usable fabrics for temperature packaging solutions, engineers found these products usable in our manufacturing processes.



Q: What motivates you to rethink packaging in your supply chain?


A: The challenge of solving problems. For example, temperature protection packaging is lightweight and if I can use a very technical engineering term, “fluffy.” Shipping air is not sustainable particularly when we consider the future availability of fuel and our focus to reduce carbon emissions. To help with these sustainable concerns, we figured out a way to remove air from our product. QProducts has invested and incorporated new technology that allows us to compress the air from our product, therefore increasing the number of units shipped per pallet. Consequently, we minimize the number of shipments to our customers. In turn, they improve their carbon footprint due to finding a better packaging method and solution.


Another important motivation to note is reducing costs. With sustainable packaging, the cost per unit to ship is dramatically reduced. The savings we may have offered our customers in the past are now the new standard. There is always an ever-driving force to develop lower cost solutions. However, don’t get me wrong, in many cases you get what you pay for. There is a correlation in price to performance. We like to call it price performance continuum.



Q: Can you share a glimpse into the future of packaging?


A: The future of packaging is technology and data analytics driven. It comes from advancements in materials, migration of other industry technologies into the manufacturing world, and just old fashion collaboration. We utilize computer simulation software to refine or enhance our design solutions on a regular basis. When you think about life sciences or healthcare, the qualification process is long and tedious. We all know the traditional steps of DQ, OQ, and PQ. With the use of computer simulations, engineers can dial in the best solution for each application, lane or pack out.


So, what is the impact on the future of packaging? We see solutions getting to market faster and being more refined, which means using less packaging material and as always, being the best cost-effective solution to the end user.


The future of packaging will also be driven through collaboration. QProducts and Services and Riskpulse are a perfect example of how our customers benefit from this collaboration. Riskpulse is a web-based software solution that uses data analysis of up-to-the-minute weather conditions. It provides intellectual risk-based scoring to help recommend preferred transportation modes for your temperature sensitive commodities.


Imagine the ability to bring data built through computer simulation and incorporating that into live weather data making decisions on which mode of transport to use – refrigerated transport, active shipper, pallet shipper, passive shipper, or simply over the road service. The future of technology is information driven.



Q: What are your main challenges?


A: Developing a truly recyclable solution and working towards curbside reliability in all our materials. Our Inspect/Clean/Recycle program for extending the performance and safe use potential of every pallet cover in a client’s network is something we strive to continuously improve.



At QProducts and Services, every quilt we make takes reefers – and their larger carbon footprint – off the road. It’s our goal to reduce the footprint of the logistics industry through safe product development and recycling programs. Learn more about our commitment to sustainability and discover more of our temperature protection solutions.




cold chain council webinar graphic

The New Normal: Evolving the Global Supply Chain with the Power of Data and Technology

May 22nd, 2020 Posted by Food & Beverage, Pharmaceutical & Life Sciences, Technology, Temperature Protection, Update 0 thoughts on “The New Normal: Evolving the Global Supply Chain with the Power of Data and Technology”

The New Normal: Evolving the Global Supply Chain with the Power of Data and Technology

Authors: QProducts & Services Digital Team, Under the Direction of Paul Yadron


cold chain council logo

The global supply chain is evolving at a quick pace due to the current global situation. The power of data is being leveraged more, delivery models are changing, and tracking and tracing is needed now more than ever. How can supply chains keep up with this change?


The Cold Chain Council, hosted by QProducts & Services, is hosting their very first webinar this summer, The New Normal: Evolving the Global Supply Chain with the Power of Data and Technology. Industry-leading speakers will provide insight and discussion about current changes and developments happening in the world of cold chain supply logistics.


industry professionals meeting at cold chain council

What is Cold Chain Council?


Cold Chain Council began three years ago to gather top talent from all phases of the cold chain – including manufacturers, retail, distribution, and logistics partners – to share their perspectives on existing challenges and best practices. An intimate afternoon of networking and expert panel discussion was created as a non-conference and thought leadership event.


The goal of the Cold Chain Council for the food and beverage market as well as the pharma and chemical industries is to present and discuss topics from different cold chain segments within the global supply chain.



Today, two events are hosted: one for the food and beverage industry and another for the pharmaceutical and chemical industries. Each event features a full day of workshops and a limited number of attendees to ensure that Cold Chain Council is an intimate, collaborative experience every year. Taking place over an afternoon to accommodate busy schedules, topics cover current cold chain challenges so that attendees leave with a fresh perspective and actionable solutions.

vp of sales speaking at cold chain council

Previous Cold Chain Council Events


Cold Chain Council for the food and beverage industries is hosted by QProducts and Services. Presentations and panels feature industry professionals discussing topics from different cold chain segments in both the food and beverage industries.


In previous events, we have had industry expert speakers including but not limited to the following:



Cold Chain Council for the pharma and chemical industries is also hosted by QProducts and Services. Experts share their knowledge in tackling challenges affecting your transportation network. Presentations and panels also feature industry professionals discussing topics from different cold chain segments in both pharma and chemical industries. This forum setting is designed to be interactive and intimate.


Previous event speakers for the pharma and chemical industries have included, but not limited to, the following:


cold chain council webinar speakersCold Chain Council Webinar Speakers


Our industry-leading speakers will provide insight and discussion about current changes and developments happening in the world of cold chain supply logistics.


Our speakers include:


  • Don Durm, a 25-year veteran of PLM Trailer Leasing and Vice President of Customer Solutions. He is a recognized industry expert on cold chain transport application, regulatory compliance, and the application of technology for a smarter food safety system. He has been recognized three times as one of the rock stars of the supply chain by Food Logistics Magazine due to his work on supply chain efficiencies, regulatory compliance, and the deployment of blockchain in the food supply chain. A gifted and sought out speaker and writer on cold chain supply challenges, he is one of the authors of the internationally accepted IRTA Refrigerated Best Practices Guide distributed by the Global Cold Chain Alliance (GCCA) to help the industry meet the compliance for the Food Safety Modernization Act.


  • Amy Shortman, a Chartered Fellow of the Institute of Transport and Logistics, has 20 plus years of experience within pharmaceutical logistics. During this time, she has worked within operations and commercial roles while keeping her passion for creating supply chains that ensure product integrity is maintained throughout. Amy has worked within the air, sea, and road arena, and has extensive experience setting up secure supply chains for high-value freight and temperature-sensitive freight. Her penultimate role before joining Overhaul was with ASC Associates, in which Amy established in 2011 as a global supply chain business services company that specializes in the areas of temperature-sensitive, high-value products. She has been facilitating and training for over 12 years and is an IATA external facilitator for CEIV Pharma.


logging into the cold chain council webinar


Cold Chain Council Webinar Details and Registration


We invite you to join us on Tuesday, June 23rd, at 11 AM CST as our speakers share examples and insight into how a new evolution of the supply chain is being forged under the pressure of the global COVID-19 pandemic.


Learn about using the power of data to gain insight into every aspect of a transportation network, a matrix of shifts and changes in delivery models, tracking and tracing supply chain disruptions and what the future holds for the global supply chain as we navigate our way through the storm driven by SARS-CoV-2. Click here to register for the webinar. We look forward to your attendance!



Air Cargo Security: Maintaining Product Quality & Preventing Threats

November 19th, 2019 Posted by Air, Food & Beverage, Pharmaceutical & Life Sciences, Transportation 0 thoughts on “Air Cargo Security: Maintaining Product Quality & Preventing Threats”

Air Cargo Security: Maintaining Product Quality & Preventing Threats

Authors: QProducts & Services Team, Under the Direction of Paul Yadron, Sr. VP of Sales





U.S. air cargo supply chain handles more than 50,000 tons of cargo each day, of which 7,500 (15%) is designated for domestic passenger carriers, and the remaining 85% is designated for all-cargo carriers, according to the Transportation Security Administration (TSA). Over the past 3-4 decades, air cargo transport has offered a means by which to expeditiously move cargo from points of production and manufacture to points of distribution and sales.


Major events over the last few decades have led to increased security measures for the air cargo supply chain, while also allowing us to learn about possible additional security threats and how to prevent them. The quick transport of products by air is especially important for perishable goods, as a major benefit of shipping goods by air is timing. So how do we secure these threats, and how do we maintain the quality of our products?


air cargo plane




What is Air Cargo Security?


First and foremost, the air cargo industry consists of a complex distribution network linking manufacturers and shippers to freight forwarders, off-airport freight consolidators, and airport sorting and cargo handling facilities where shipments are loaded on and unloaded from an aircraft. Under the Aviation Transport Security Act of 2004, air cargo is defined as goods, other than baggage or stores, that are transported by aircraft. Items shipped by aircraft generally consist of time-sensitive and high-value commodities. Common examples of air cargo include high-value machine parts and manufacturing equipment, electronic components for manufactured goods, consumer electronics, jewelry, and perishable items such as flowers, fruits, fresh fish, and pharmaceuticals.


Air cargo security measures aim to protect cargo from theft, but they also secure cargo against incoming materials such as bombs or drugs. Security is a very critical element of the air cargo supply chain. Regulators, organizations, and the industry overall are working together to further secure the air cargo supply chain while ensuring the flow of commerce.


palletized technology


Maintaining Air Cargo Product Quality


As we discussed, a major benefit to shipping items via air is time. The faster a product can get to its destination, the better. When it comes to food, beverage, and pharmaceuticals, these items cannot last very long in transit as the biggest challenge of keeping perishable products fresh has to do with temperature.  The longer an item stays exposed to high temperatures, the quicker it loses its freshness. We all know that temperature-controlled shipping is critical for delicate materials such as pharmaceuticals, medicines, and food.


For the pharmaceutical industry, the IATA (International Air Transport Association) Time and Temperature Sensitive Label became effective July 1st, 2012. This label ensured the integrity of the time and temperature of sensitive healthcare air cargo shipments and also ensured that the air cargo supply chain is prepared to handle the demands of these healthcare shipments. The overall aim is to ensure patient safety through effective cold chain distribution. Therefore, it is imperative that airlines, ground handling agents, and other stakeholders within the supply chain are familiar with the regulations and appearance of the label. It is also imperative that effective cold chain solutions are put into place to secure the successful air transit of healthcare products.


Unfortunately, one of the main costs with the transportation of perishable items such as fruit and vegetables is wastage due to spoilage related to inadequate temperature management during transit. Keeping perishable food items cool, cold, frozen, or deep frozen is the only way to guarantee product quality and shelf-life as it arrives at the end of a transportation process. Leveraging the proper cold chain equipment such as palletized technology can increase product shelf-life, increase profits, and reduce food loss.


security and protection for air cargo



Security Threats to Air Cargo


In the United States, security of air cargo shipments and international shipments to and from the U.S. is regulated by the Transportation Security Administration (TSA). Security threats can impact product integrity and create safety issues in certain markets. Security threats can damage the product altogether, resulting not only in lost product, but additional costs. Historically, security measuring surrounding all-cargo operations have focused on the threat of hijackings, particularly those that could result in using the aircraft as a weapon of mass destruction. According to the Congressional Research Service, a 1994 incident involved an off-duty FedEx flight engineer who attempted to hijack a FedEx DC-10 aircraft and crash it into the company’s Memphis, TN headquarters. At the time, there was no federal requirement to screen personnel or personal baggage carried aboard cargo aircraft. This particular hijack attempt was unsuccessful; however, the threat still remains in the air cargo industry.


Another security threat to air cargo includes the threat of explosives. A long-standing concern for cargo loaded on passenger aircraft, several incidents have shown that U.S. bound air cargo shipments are targeted. For instance, the Congressional Research Service reports that on October 29, 2010, intelligence and law enforcement agencies in Dubai, United Arab Emirates, and in the United Kingdom discovered explosive devices concealed in packages shipped as air cargo bound for the United States. Authorities in the U.S. were able to bring down the aircraft; however, the details of this incident highlighted a number of specific challenges to securing air cargo. First, the explosives were difficult to detect using explosive detection equipment and canines. Second, questions were raised regarding the implementation and effectiveness of risk-based targeting methods to identify suspicious cargo. And third, the multiple international airports and air cargo facilities that served as intermediate transfer points illustrated the highly interconnected nature of the international air cargo industry, which necessitates close collaboration and coordination among governments, forwarders, air carriers, and airport operators to address security.


While we don’t want to assume this threat, the “Insider Threat” still presents a threat to air cargo security. While shippers may have limited ability to target a specific aircraft or even predict if an item will move on a passenger aircraft or an all-cargo aircraft, insiders working in the air cargo industry could use their access and knowledge to carry out an attack. The Congressional Research Service states, “Historically, in the United States, air cargo supply chains have been infiltrated by organized criminal elements conducting systematic theft and smuggling operations. Overseas, there is growing concern that terrorist networks could infiltrate airports and air cargo operations to gather information about possible weaknesses and exploit vulnerabilities in the supply chain.”


Lastly, theft is a very real concern in the supply chain, including the air cargo supply chain. While cargo is more vulnerable to theft when hauled by a truck, cargo theft gangs are seeking opportunities to steal cargo from airports as some items shipped by air tend to be high value items. According to Air Cargo Eye, in February 2017, thieves escaped with rare 15th and 16th century antique books valued at more than $2.3 million after they broke into a facility at London’s Heathrow Airport. In March 2017, thieves were seen masquerading as police officers while using what were reported as police vehicles intercepting a cargo of $1.7 million of banknotes shortly after the aircraft had arrived at Johannesburg’s OR Tambo International Airport.


transportation security administrationPreventing Air Cargo Threats


Whereas the air cargo industry has favored risk-based approaches for both cargo planes and cargo placed aboard passenger aircraft, some policymakers have argued that more comprehensive screening of cargo is needed to make cargo security comparable to the screening of airline passengers and baggage. The 9/11 Commission Act of 2007 required 100% physical screening and inspection of all cargo placed on passenger aircraft. Acceptable screening methods include x-ray systems, explosives detection systems, explosives trace detection, TSA-certified explosives detection canine teams, and physical searches conducted in conjunction with manifest verifications. Cargo documents and known shipper verification are not acceptable screening methods.


While TSA has approved a number of detection systems for screening air cargo to meet the requirements of the 100% screening mandate, none of these devices have been approved for the screening of palletized or containerized cargo. According to the Congressional Research Service, it is estimated that palletized cargo makes up 75% of all cargo carried on passenger planes. The lack of an approved technology for screening pallets leaves the industry dependent on work-around solutions, largely involving the off-airport screening of cargo combined with approved supply-chain security measures to prevent tampering after the item is screened.


In regard to air cargo theft, organizations can take the following actions to help prevent theft in the industry:

  1. Thoroughly screen prospective employees
  2. Carefully select transportation partners and intermediaries
  3. Provide security training within your organization
  4. Incorporate surveillance into the duties of security guards, and have guards patrol away from perimeters
  5. Leverage technology such as equipment tracking, security seals, or locks
  6. Periodically conduct security audits


In addition to the organizations themselves being involved, various supply chain security measures provide options for preventing and detecting tampering while maintaining the integrity of the shipment. These measures include tamper-evident and tamper-resistant packaging, cargo tracking technologies, and identifiers to designate screened cargo.


air cargo packages



Final Thoughts


Today, thousands of products are being delivered by air freight. This service has made it possible for people and organizations around the world to have the goods needed for everyday life. Several industries have been able to grow internationally due to air freight, although there are challenges faced along the way.


The industry still faces the challenge of security threats and how to combat them to ensure the safety of the product and passengers. Technology continues to advance to screen cargo for these threats, and technology advances even further to maintain product quality and safety aboard an aircraft. The Federal Aviation Administration (FAA) forecasts that steady U.S. and world economic growth will drive more modest annual increases of about 3% in air cargo shipments over the next two decades. Innovation, education, and due diligence will continue to help the industry combat air cargo security.


As the air cargo supply chain continues to grow, I hope this information was helpful in answering some of your questions regarding air cargo, security, safety, and product quality.







Cold Chain Council for what should be on your whiteboard for2020-2030

Prepare Your Cold Chain for the Next Decade

November 12th, 2019 Posted by Pharmaceutical & Life Sciences, Technology, Temperature Protection, Update 0 thoughts on “Prepare Your Cold Chain for the Next Decade”

The Cold Chain transportation experts at QProducts & Services present the 5 innovations you should include on your cold chain whiteboard for 2020-2030.





Our annual gathering of industry leaders at the Cold Chain Council for the Pharma & Chemical Industries took place October 1st, 2019 in Chicago, IL. As a result, attendees left armed with knowledge to help them strategically plan their cold chain operations for the next decade. Thus, there are many things going on socially, logistically, and environmentally to be aware of, from blockchain to medical drone deliveries.


In summary, here are the top 5 innovations to put on your cold chain whiteboard for 2020-2030:



Additional information and resources in regard to these technological innovations is below:


Drones that deliver blood and medical supplies are saving lives as they provide faster, efficient care by supplying medicine, pharmaceuticals, vaccines, and emergency medical equipment. Drone delivery has begun to disrupt both the transportation and pharmaceutical and medical industries as they allow improved access to medical supplies, especially in rural areas. Learn more about how drone delivery and drone technology is shaping the future of these industries. For further information on this topic, please visit the following resources:

  1. Drones in Healthcare
  2. What is Drone Delivery and How is it Changing the Pharmaceutical Supply Chain?
  3. Drones Delivering Medical Supplies and More Can Help Save American Lives



The pharmaceutical industry is actively exploring blockchain technology to help with the tracking and tracing of products, product provenance, and supply chain governance. Blockchain technology also provides the opportunity to decrease costs and increase transparency and trust during clinical trials. Blockchain technology could be a major solution to a $450 billion U.S. industry. Read more about how blockchain is revolutionizing the pharmaceutical and medical industry. For further information on this topic, please visit the following resources:

  1. How Blockchain Will Revolutionize the Pharmaceutical Industry
  2. Pharma Meets Blockchain – Solution to $450 Billion U.S. Industry
  3. Five Use Cases for Blockchain in Pharma


Augmented Reality (AR)

Augmented reality holds the ability to visualize production processes, which could help to improve pharmaceutical manufacturing. However, the value of augmented reality not only lies in manufacturing, but in patient outcomes as well. Augmented reality is now being used to help reduce patient pain and anxiety levels in patients without the need for additional medication. Learn more about how augmented reality is transforming these industries. For further information on this topic, please visit the following resources:

  1. The Future is Mixed Reality: Augmented Reality Put to Work on Manufacturing
  2. 8 Benefits of Virtual Reality in the Pharmaceutical Industry
  3. Augmented Reality in Healthcare Will Be Revolutionary


IoT – Internet of Things

The pharmaceutical and medical industry is perfectly positioned to benefit from IoT, or the Internet of Things. The data collected can have a significant impact on the production and administration of pharmaceuticals, while helping to smooth logistics, eradicate recalls, and improve operational efficiency. Learn more about the IoT and its impact on pharmaceutical and medical. For further information on this topic, please visit the following resources:

  1. How is IoT Transforming the Pharmaceutical Industry?
  2. How Can the Pharmaceutical Industry Benefit from the IoT?
  3. How IoT is Revolutionizing the Pharma Industry


QProducts & Services extends their gratitude to the many industry experts that spoke at our event.

Together, our speakers educated attendees on how to best leverage the latest innovations for their 2020-2030 cold chain operations.


QProducts & Services is a manufacturer of passive temperature protection and cargo security solutions for the global supply chain. For over 25 years, they have developed innovative, cost-saving solutions for transporting temperature sensitive commodities. QProducts & Services has expanded their product line to include cargo security solutions and wireless temperature monitoring technologies. Manufactured just outside of Chicago, IL, their patented products are noted for durability, performance and reliability in protecting the integrity of shippers’ cargo throughout the supply chain.

Cannabis Disruption in the Pharma & Chemical Industry

October 18th, 2019 Posted by Pharmaceutical & Life Sciences, Transportation 0 thoughts on “Cannabis Disruption in the Pharma & Chemical Industry”

Cannabis Disruption in the Pharmaceutical & Chemical Industry

Authors: QProducts & Services Pharma & Chemical Team, Under the Direction of Jim O’Donnell





The recent and continuous growth of the cannabis industry has attracted many businesses to join in on this lucrative and evolving space. With the recreational use of cannabis now legal in 11 states, and medical marijuana legal in 33 states, cannabis is on its way to possibly becoming an $80 billion industry by 2030, according to estimates by Cowen, Inc. The explosive growth of this space in a short period of time has created a need for a new era of supply chain management to help adapt to new regulations, distribution models, and other challenges related to a highly regulated but thriving industry, according to Green Entrepreneur. In the pharmaceutical and chemical industries specifically, we’re experiencing the continuous rise of medicinal marijuana and new insights for Big Pharma and its supply chain.


What is Cannabis?

Cannabis, also referred to as marijuana, comes from a group of three plants with psychoactive properties: Cannabis sativa, Cannabis indica, and Cannabis ruderalis. When the flowers of these plants are harvested and dried, you’re left with cannabis, one of the most common drugs in the world. It is made up of more than 120 components, also known as cannabinoids, of which we can find cannabidiol (CBD) and tetrahydrocannabinol (THC). While THC is psychoactive, CBD is not, and you can find cannabis products that contain just CBD, THC, or a combination of both.


cannabis plant

Where Did CBD Come From?


Cannabidiol (CBD) is a compound extracted from hemp or marijuana. The 2018 Farm Bill excluded hemp from the definition of marijuana and removed it from the Controlled Substances Act (CSA).


CBD was first discovered by Dr. Roger Adams and his team at the University of Illinois in 1940, however, its structure was not made clear until 1963. While it may lead some to assume that CBD is a newly discovered ingredient, cannabis and CBD have a history that dates back thousands of years. According to CBD Origin, the first documented use of cannabis-derived medicine dates back to 2737 B.C. It can be said that Chinese Emperor Sheng Nung used a cannabis-infused tea to aid with a variety of ailments including memory, malaria, rheumatism, and gout. Throughout history, cannabis and CBD have been used for therapeutic purposes, however, during the rise of modern medicine, it was not recognized due to a lack of scientific evidence.


More recently, and with the legalization of medical marijuana, researchers have been prompted to dive more into CBD and its potential medicinal uses. While the stigma towards CBD and cannabis has changed over the last few decades in the United States, we are still in the early stages of research, legalization, and recreational use. However, with the federal legalization of hemp and hemp-derived CBD, more and more CBD products are being sold online by major retailers including Sephora and Neiman Marcus.


cbd oil


The Legalization of Hemp


The Agriculture Improvement Act of 2018, also known as the 2018 Farm Bill, was signed on December 20th, 2018, and will remain in force through 2023. The passing of the 2018 Farm Bill allowed the legalization of hemp agriculture and products in all 50 U.S. states. In the United States, hemp plants are defined as any cannabis plant that has 0.3 percent or less THC. Any cannabis plant that has a THC content greater than 0.3 percent is classified as marijuana. From a chemical composition standpoint, hemp cannot get you high.


According to Analytical Cannabis, the increased legality of hemp is largely to thank for the rapid acceleration in diversity and availability of hemp-derived CBD oil. Unless you go to a marijuana dispensary to purchase CBD oil, the CBD oil that you find is made exclusively from the hemp plant, which is also referred to as hemp oil or CBD hemp oil. Since CBD can be extracted from hemp, CBD is legal. However, there is still work to be done when it comes to FDA regulation. According to a leader of the U.S. Food and Drug Administration’s new cannabinoid work group, there is more research to be done before federal authorities can allow CBD treatments into food and beverage products. Just like any other new ingredient going into food or drugs, the FDA is unlikely to approve over-the-counter use without further research on the ingredient and its health benefits. With that being said, certain companies with a loyal customer base are likely to wait until CBD is FDA approved prior to marketing CBD products to consumers. While FDA approval is in the works, fortune 500 companies are educating themselves on the evolving market, investing heavily, and laying the groundwork within their networks.


The History of Medicinal Cannabis


Medicinal cannabis, also referred to as medicinal marijuana, has been widely known for its use in medical treatments and therapy, which has garnered national attention in recent years. While evidence suggests cannabis use more than 5,000 years ago in what is now Romania, there is only one direct source of evidence that cannabis was first used medicinally around 400 A.D. In the U.S., cannabis was widely utilized as a patent medicine during the 19th and early 20th centuries. According to Medical Daily, in the late 1700s, some American medical journals were suggesting using hemp seeds and roots to treat various health problems, including skin inflammation and incontinence. William O’Shaughnessy was an Irish doctor in the British East India Company who touted medical marijuana’s benefits for rheumatism and nausea in England and America.


The Marijuana Tax Act was the very first federal restriction of cannabis use and cannabis sale, taking effect in 1937. Subsequent to the act of 1937, legal penalties for possession of the drug began to increase in 1951 and 1956 with the enactment of the Boggs and Narcotic Control Acts. In 1970, prohibition under Federal Law occurred with the Controlled Substances Act and marijuana was classified as a Schedule 1 drug. Then, in 1996, California became the first state to allow legal access to and use of cannabis for medicinal purposes under physician supervision with the enactment of the Compassionate Use Act. According to Business Insider, medical marijuana is legal in 33 states in 2019. Medical Daily also states that only people with certain qualifications can obtain the drug. That will usually entail children with epileptic conditions, or sometimes cancer patients who use cannabis to ease the side effects of chemotherapy or radiation. Some states allow patients with HIV/AIDS, Parkinson’s disease, multiple sclerosis, or even Chron’s disease to obtain medical cannabis.


pharmaceutical cannabis


The Rise of Medicinal Cannabis


As restrictions are lifted and research into medical cannabis continues, more recent research has started to explore more of its therapeutic benefits. For instance, a 2015 study found that cannabis could be effective in treating schizophrenia. In addition, research has shown that the drug can help stop severe seizures and even cure migraines.


According to Harvard Health, the most common use for medical marijuana in the United States is for pain control. While marijuana isn’t strong enough for severe pain (for example, post-surgical pain or a broken bone), it is quite effective for the chronic pain that plagues millions of Americans, especially as they age. In 2014, a survey conducted in California found that medical marijuana patients agree that the drug works as 92 percent of them said that medical marijuana alleviated symptoms of their serious medical conditions including chronic pain, arthritis, migraines, and cancer. According to WebMD, the number of registered U.S. medical marijuana patients rose from more than 641,000 in 2016 to nearly 814,000 in 2017. In states where medical marijuana is legal, there seems to be somewhat of a general consensus that it is helpful in treating a variety of ailments. However, for more serious conditions, pharmaceuticals remain a necessity for patients.


medicinal cannabis


Disruption Within the Pharmaceutical Industry


Marijuana’s growing availability, both recreationally and medically, is impacting the pharmaceutical industry in various ways. First, the cost of healthcare could decrease for people who use marijuana as a treatment. This could reduce healthcare costs for the rest of the U.S., as well. However, lower costs also means less profits for doctors, hospitals, and the pharmaceutical companies. The reduced need for pain medications or even mental health medications is a great example of the current disruption occurring within these industries. According to Health Care in America, on average, in states where medical cannabis is legal, doctors prescribe upwards of 260 fewer doses of antidepressants and 560 fewer doses of anxiety medication than in other states, per doctor. A survey of more than 1,300 U.S. cannabis consumers, conducted by JAMA Internal Medicine, found that about 80% had used marijuana as a substitute for pharmaceuticals, primarily opioids. As Green Thumb Industries stated, “Every day, more and more patients are opting to use it as a replacement to traditional prescription medications that may cause unwanted side effects.” This presents the opportunity for pharmaceutical companies to invest in the medical marijuana market to develop products or participate in research.


Second, it’s important to note that other drug companies are starting to invest more time and money in cannabis research now that 33 states and the District of Columbia allow medical marijuana. For example, the pharmaceutical industry has sponsored more than 120 federal clinical trials involving cannabinoids, or chemicals that are unique to the marijuana plant. Additionally, GW Pharmaceuticals recently received federal approval for the epilepsy treatment Epidiolex, the first prescription drug derived from cannabis. Also, the Canadian marijuana company, Tilray, announced in December 2018 that they have signed an agreement to partner with Novartis subsidiary, Sandoz, to sell medical marijuana in countries where it is legal.


According to Investor’s Business Daily, companies ranging from small biotech stocks to giant pharma companies such as AbbVie are exploring cannabis medicine and what products can be derived from it. Many companies are in the startup phase, but hundreds of studies are underway on possible uses for cannabis. Additional companies working in cannabis medicine that are studying laboratory-created cannabinoids include Cara Therapeutics, Corbus Pharmaceuticals, Insys Therapeutics, and Zynerba Pharmaceuticals.

scientist measuring cannabis Challenges in the Supply Chain


In the U.S., California’s market is by far the largest in both geography and in the number of users regarding the cannabis industry. California distributors believe that they can develop reliable logistics to support the current cannabis market that would solve challenges across other regions, should cannabis become legal at the federal level. Currently, the nation faces the challenge of cannabis distribution as federal laws currently prohibit the transportation of cannabis across state lines. Because cannabis is illegal at the federal level, freight trucks that are regulated by the Department of Transportation are unable to carry cannabis. In addition to logistics operations, the cannabis industry still faces the stigma against the trade and the challenges that come with financial transactions as well.


As for medical marijuana, the same restrictions apply as medical marijuana is not yet legal in all 50 U.S. states. Changing national laws will make it easier to work with the cannabis industry in states where it is legalized, but the real breakthrough will be full, nationwide legalization that allows for interstate commerce.


pharmaceutical supply chain


Final Thoughts


The legalization of medicinal marijuana presents both opportunities and challenges for the pharmaceutical and chemical industry. For many pharmaceutical companies, the chance to service a market with predictable high margins is definitely a growth factor. If and when cannabis is removed from its Schedule 1 status, the flood-gates are expected to open even further.


As cannabis continues to have an impact on the pharmaceutical and chemical industry, I hope this information was helpful in answering some of your questions regarding the rise of medicinal marijuana and how it is expected to impact these industries.

What’s On Your Supply Chain White Board for 2020?

September 9th, 2019 Posted by Pharmaceutical & Life Sciences, Technology, Update 0 thoughts on “What’s On Your Supply Chain White Board for 2020?”

Top pharma executives and supply-chain tech experts to gather in Chicago for 4th Annual Cold Chain Council meeting





October 1st in Chicago’s’ Museum Campus district will mark the 4th Cold Chain Council for the pharma, healthcare and chemical industries. This educational forum will feature panel discussions and presentations by top executives and tech experts discussing the new decade ahead, trends in supply chain tech and best practices for 2020.


With a key focus on furthering the industry and advancing best practices in the supply chain and cold chain respectively, the main goal of the Cold Chain Council is to bring together high-level industry professionals to share in thought leadership and create a casual platform for discussion of real world challenges and solutions derived from everyday experiences of speakers and attendees alike. Hosted by QProducts & Services, there are no other sponsors, no fee to attend, and attendance is capped to provide an informal and informative feel for one afternoon in Chicago.


Amy ShortmanThis year’s event will be moderated by Amy Shortman, a senior executive at Overhaul Group. Her keynote will set the scene for the day’s discussion on how technology will affect traditional supply chains, the scope of our working environment and the benefits that may arise. Amy’s expertise stems from more than twenty years of pharmaceutical logistics experience. A Chartered Fellow of The Institute of Transport and Logistics, Amy has become a well-known thought leader in education and brand awareness to the healthcare and logistics industry’s need for improved compliance and cool chain management, backed by her professional career including roles in operations for a global logistics provider of clinical trials, a world-leading temp-controlled container company, supply chain security for a “Top 3” third-party logistics provider and eventually establishing a global supply chain business services company, ASC Associates Ltd, specializing in high-value and temp-sensitive freight.


(for Amy Shortman’s full bio click here)


Amy will be in good company with an impressive line-up of industry experts hailing from a diverse group of companies: Big Pharma shippers AbbVie and McKesson; the World Federation of Hemophilia; computer-aided environment-software developer Smart CAE; smart technology manufacturers SensorTransport Inc and Berlinger USA; and advanced predictive risk-analysis software developer Riskpulse. Session topics have been locked in and speakers are teaming up to lead discussions in what promises to be an informative afternoon of interactive discussion and networking. The setting overlooks Chicago’s museums and lake front to the East and impressive skyline and Grant Park to the North. Here’s a taste of the agenda and talented roster:


Session One: Wild Weather and Adapting to The New Norm. Lane Analysis and Risk Visibility Through Advanced Forecasting and Data Analytics. Mark Russo, SVP of Weather Operations, Riskpulse


Session Two: Cold Chain Tech 2020. Service, Equipment and Qualification Innovations for The New Decade.
Stefan Braun, Managing Director, Smart CAE and Stephen Dusel, Sales Manager North, Berlinger USA


Session Three: Big Pharma Cold Chain Report. What’s New as We Look Ahead into The Twenties?
David Ulrich, QA Director of Global Supply Chain Compliance, Abbvie and Georgios Ampartzidis, Logistics Manager-Humanitarian Aid, World Federation of Hemophilia


Session Four: Digitization and IoT’s Continuing Impact on the Supply Chain. Michael Dee, VP of Global Security, McKesson; Amy Shortman, Director of Product Marketing, Overhaul Group Inc.; and Sascha Peyer, Co-Founder and CCO, SensorTransport, Inc.

(Full event details here)

Cold Chain Council Chicago


The afternoons’ sessions conclude with an interactive discussion between attendees and speakers, including an opportunity for Q&A before wrapping up and moving on to the evenings festivities.


The networking portion of the Cold Chain Council agenda includes cocktails and dinner reception at the Chicago Yacht Club followed by a private yacht cruise down the Chicago River at nightfall.




For more information on content and key takeaways from this event, connect with event hosts QProducts & Services on LinkedIn or visit the Cold Chain Council homepage for other CCC events and an opportunity to attend.

Think of a question? Want to learn more?
q products and services logo

If you're searching for thermal shipping, insulated shipping containers, pallet wraps, thermal blankets, insulated foil, banana blankets, tote covers, drum covers, thermal blankets, shipping blankets, electronic cargo locks, or ice cream bags, you found all that and a whole lot more. We are fully committed to providing a passive thermal solution from top to bottom, nose to rear, of your temperature sensitive cargo.

Contact Us

16720 Mozart Ave.
Hazel Crest, IL 60429

© 2021 QProducts & Services

Wordpress Social Share Plugin powered by Ultimatelysocial